Should a statin be prescribed to every patient with heart failure?
Chronic heart failure (HF) represents an emerging epidemic since its prevalence is continuously increasing despite advances in treatment. Many recent clinical studies have clearly demonstrated that statin therapy is associated with improved outcomes in HF irrespective of aetiology (ischaemic or not) or baseline cholesterol levels. Indeed, most of the conducted large statin trials and trials in HF have demonstrated a positive effect of statins in HF patients. Furthermore, the use of statins in HF seems to be safe as none of the recent trials has resulted in worse outcomes for HF patients treated with statins. Potential mechanisms through which statins could benefit the failing myocardium include non-sterol effects of statins, as well as effects on nitric oxide and endothelial function, inflammation and adhesion molecules, apoptosis and myocardial remodelling and neurohormonal activation. This review discusses the pathophysiological basis of statin effects on HF and focuses on clinical data for the benefit from statin use in this setting. Until today there are no official recommendations in both the American and the European guidelines regarding the use of statins in HF patients, as the available data come from small observational or larger but retrospective, non-randomised studies. Therefore, HF patients should be treated according to current lipid guidelines. Large randomised clinical trials are underway and will further delineate the role of statin therapy in HF patients. Until more data are available, we could not recommend statin use to every patient with HF irrespective of HF aetiology and baseline cholesterol levels.
Tsouli
Sofia G
SG
Department of Internal Medicine, School of Medicine, University of Ioannina, Ioannina 45110, Greece. stsouli@hotmail.com
Liberopoulos
Evangelos N
EN
Goudevenos
John A
JA
Mikhailidis
Dimitri P
DP
Elisaf
Moses S
MS
D002986:Clinical Trials as Topic; D011307:Drug Prescriptions; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D013318:Stroke Volume / Q000187:drug effects / Q000502:physiology; D016896:Treatment Outcome
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors
Heart Fail Rev. 2003 Jan;8(1):99-106
12652163
Am J Cardiol. 2006 Mar 15;97(6):899-904
16516598
Am J Kidney Dis. 2006 Mar;47(3):561; author reply 562
16490637
Cardiovasc Drugs Ther. 2005 May;19(3):167-8
16142591
J Card Fail. 2005 Dec;11(9):684-90
16360963
Lancet. 1999 May 29;353(9167):1838-42
10359409
Circulation. 2006 Feb 7;113(5):671-8
16461840
Eur J Heart Fail. 2001 Jun;3(3):315-22
11378002
Eur J Heart Fail. 2001 Jun;3(3):381-7
11378012
Eur J Heart Fail. 2004 Aug;6(5):635-41
15302013
Am Heart J. 2004 Oct;148(4):635-40
15459594
Acta Cardiol. 2005 Oct;60(5):489-92
16261779
J Cell Biochem. 1997 Jul 1;66(1):43-53
9215527
J Clin Invest. 1998 Jun 15;101(12):2711-9
9637705
BMC Med. 2005 Mar 16;3:6
15771782
Nature. 2002 Dec 12;420(6916):629-35
12478284
JAMA. 2004 Sep 15;292(11):1307-16
15337732
Am Heart J. 2000 Jan;139(1 Pt 1):72-7
10618565
Circulation. 2003 Aug 19;108(7):839-43
12885745
Arch Intern Med. 2005 Jan 10;165(1):62-7
15642876
N Engl J Med. 1996 Oct 3;335(14):1001-9
8801446
Hellenic J Cardiol. 2005 May-Jun;46(3):208-11
15981556
Minerva Cardioangiol. 2004 Dec;52(6):465-77
15729208
Arch Intern Med. 2001 Apr 9;161(7):996-1002
11295963
N Engl J Med. 1990 Jul 26;323(4):236-41
2195340
Am J Cardiol. 2005 Dec 15;96(12):1699-704
16360360
Circulation. 2003 Apr 22;107(15):1991-7
12707250
Am J Kidney Dis. 2004 Apr;43(4):589-99
15042535
J Am Coll Cardiol. 2006 Jan 17;47(2):338-41
16412857
Eur J Heart Fail. 2005 Jun;7(4):468-74
15921781
Lancet. 2000 Sep 9;356(9233):930-3
11036910
Atherosclerosis. 2005 Mar;179(1):201-6
15721028
Circulation. 2005 Jul 19;112(3):357-63
16009792
Mol Aspects Med. 1997;18 Suppl:S137-44
9266515
Lancet. 2005 May 21-27;365(9473):1766
15910945
Cardiovasc Res. 2003 Nov 1;60(2):250-8
14613854
JAMA. 2005 Feb 2;293(5):572-80
15687312
Circulation. 2006 May 16;113(19):2363-72
16702489
Curr Med Res Opin. 2005 Feb;21(2):231-44
15801994
J Am Coll Cardiol. 2006 Jan 17;47(2):332-7
16412856
J Am Coll Cardiol. 2004 Feb 18;43(4):642-8
14975476
Eur Heart J. 2001 Feb;22(3):228-36
11161934
Heart. 2004 Apr;90(4):464-70
15020532
Clin Cardiol. 2004 May;27(5):295-9
15188947
Cardiovasc Res. 2005 Jun 1;66(3):427-9
15914106
Obes Rev. 2005 Nov;6(4):283-96
16246214
Curr Drug Targets. 2006 Feb;7(2):211-28
16475962
Int Heart J. 2005 Sep;46(5):845-54
16272775
Ter Arkh. 1989;61(5):68-9
2781495
Eur Heart J. 1997 Mar;18(3):470-9
9076385
Curr Med Res Opin. 2002;18(4):220-8
12201623
J Cardiovasc Pharmacol. 1999 Mar;33(3):473-8
10069684
N Engl J Med. 2005 Apr 7;352(14):1425-35
15755765
Circulation. 2003 Apr 22;107(15):1951-3
12707249
J Am Coll Cardiol. 2003 Dec 3;42(11):1933-40
14662255
Science. 1995 Apr 14;268(5208):221-5
7716512
Cell Mol Immunol. 2005 Dec;2(6):433-7
16426493
N Engl J Med. 1998 Nov 5;339(19):1349-57
9841303
Nat Med. 2000 Sep;6(9):1004-10
10973320
Circulation. 2003 Sep 30;108(13):1567-74
12963641
Atherosclerosis. 2005 Feb;178(2):387-97
15694949
Circulation. 2002 Apr 9;105(14):1727-33
11940554
Vascul Pharmacol. 2005 Apr-May;42(5-6):265-70
15922259
Cardiology. 1999;91(4):215-9
10545675
Cardiovasc Drugs Ther. 2005 May;19(3):183-7
16142595
Eur J Heart Fail. 2005 Dec;7(7):1126-32
16051518
Arch Intern Med. 2004 Oct 25;164(19):2162-8
15505131
J Clin Invest. 1989 May;83(5):1774-7
2540223
J Clin Pathol. 2004 Jul;57(7):728-34
15220366
Eur Heart J. 2003 Sep;24(17):1601-10
12964575
JAMA. 2001 May 16;285(19):2486-97
11368702
J Am Coll Cardiol. 2007 Jan 23;49(3):311-9
17239712
Atherosclerosis. 2004 Jul;175(1):187
15186966
Eur Heart J. 1997 May;18(5):858-65
9152657
Circulation. 2003 Jul 1;107(25):3133-40
12796126
Curr Med Res Opin. 2006 Mar;22(3):511-28
16574035
Circulation. 2006 Feb 28;113(8):1086-92
16490817
Proc Natl Acad Sci U S A. 1987 Dec;84(24):9265-9
2827174
J Hum Hypertens. 2006 May;20(5):320-35
16511505
J Am Coll Cardiol. 2006 Jun 6;47(11):2326-31
16750703
Circulation. 1998 Mar 31;97(12):1129-35
9537338
Drugs. 1990;39 Suppl 4:10-21; discussion 22-4
2354670
Am J Cardiol. 2004 May 1;93(9):1124-9
15110204
J Cardiovasc Pharmacol Ther. 2006 Mar;11(1):1-15
16703216
Lancet. 2002 Jul 6;360(9326):7-22
12114036
Circ Res. 2002 Nov 29;91(11):988-98
12456484
Hellenic J Cardiol. 2005 Jan-Feb;46(1):5-8
15807388
Circulation. 2001 Jan 23;103(3):357-62
11157685
Circulation. 2003 May 20;107(19):2493-8
12695293
J Am Coll Cardiol. 2004 Nov 2;44(9):1772-9
15519006
J Card Fail. 1997 Dec;3(4):249-54
9547437
Curr Opin Lipidol. 2005 Dec;16(6):630-4
16276240
Hellenic J Cardiol. 2006 Mar-Apr;47(2):51-3
16752523
Am Heart J. 1999 Aug;138(2 Pt 1):273-84
10426839
Circulation. 2000 Aug 8;102(6):611-6
10931799
JAMA. 2005 Nov 16;294(19):2437-45
16287954
Science. 1998 Jan 23;279(5350):509-14
9438836
Biofactors. 2003;18(1-4):79-89
14695923
Z Kardiol. 2004 Feb;93(2):103-8
14963675
Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3362-6
1314387
J Biol Chem. 1998 Sep 11;273(37):24266-71
9727051
Circulation. 1999 Jun 29;99(25):3224-6
10385494
Am J Cardiol. 2006 Apr 15;97(8):1165-71
16616020
Circulation. 2004 Jul 13;110(2):227-39
15249516
BMC Nephrol. 2006 Mar 06;7:3
16515712
Eur Heart J. 2005 Jun;26(11):1115-40
15901669
Eur J Vasc Endovasc Surg. 2004 Jan;27(1):6-16
14652831
Ann Med. 2003;35(6):398-403
14572163
Circulation. 2002 Feb 19;105(7):868-73
11854129
Heart Rhythm. 2006 Aug;3(8):881-6
16876733
Lancet. 2002 Nov 23;360(9346):1623-30
12457784
Int J Cardiol. 2005 Oct 20;105(1):67-73
16207547
Am J Cardiol. 2005 Mar 1;95(5):619-22
15721103
Hypertension. 2002 Jan;39(1):87-92
11799084
Cardiovasc Res. 2006 Aug 1;71(3):443-54
16730683
J Card Fail. 2006 Mar;12(2):134-8
16520262
Am J Cardiol. 2004 Nov 1;94(9):1166-8
15518612
Circ Res. 2000 Jun 9;86(11):1107-13
10850960
Eur J Heart Fail. 2005 Oct;7(6):1059-69
16227145
J Pharmacol Exp Ther. 1997 Feb;280(2):839-45
9023298
Timely Top Med Cardiovasc Dis. 2005 Feb 04;9:E1
15824760
Curr Atheroscler Rep. 2003 Sep;5(5):372-8
12911847
J Card Fail. 2005 Oct;11(8):607-12
16230264
Circulation. 2007 Feb 6;115(5):576-83
17261662
Atherosclerosis. 2005 Feb;178(2):359-63
15694946
N Engl J Med. 2002 Aug 1;347(5):305-13
12151467
Ann Intern Med. 2004 Jun 1;140(11):857-66
15172899
Heart. 2005 Jan;91(1):1-2
15604317
J Heart Lung Transplant. 2005 Aug;24(8):1114-7
16102449
Heart. 2006 Oct;92(10):1409-13
16717067
J Am Coll Cardiol. 2004 Oct 19;44(8):1587-92
15489090
Cardiology. 1998 Mar;89(3):184-8
9570432
JAMA. 2006 Nov 1;296(17):2105-11
17077375
Clin Cardiol. 2000 Jul;23(7 Suppl 4):IV4-8
10894449
Eur Heart J. 1998 Dec;19(12):1814-22
9886724
Am J Cardiol. 1996 May 1;77(11):1017-20
8644628
Cardiovasc Res. 2003 Nov 1;60(2):217-9
14613847
Am Heart J. 2006 Sep;152(3):514-20
16923423
J Card Fail. 2006 Aug;12(6):464-72
16911914
Am J Physiol Heart Circ Physiol. 2004 Apr;286(4):H1425-32
14644762
Coron Artery Dis. 2004 Aug;15(5):247-50
15238820
Am J Med Sci. 2006 Dec;332(6):361-3
17170629
Metabolism. 2006 Oct;55(10):1293-301
16979398
Circulation. 2005 May 10;111(18):2356-63
15867181
Angiology. 2002 Sep-Oct;53(5):493-502
12365855
J Card Fail. 2002 Aug;8(4):216-24
12397569
Circulation. 1998 Apr 21;97(15):1453-60
9576425
Am J Cardiol. 2004 Mar 1;93(5):603-6
14996587
J Am Coll Cardiol. 2006 Feb 21;47(4):769-73
16487843
Arterioscler Thromb Vasc Biol. 1995 Oct;15(10):1652-9
7583540
J Am Coll Cardiol. 2006 Jan 17;47(2):342-4
16412858
JAMA. 2001 Apr 4;285(13):1711-8
11277825